Benchmark’s Bill Gurley, CoreWeave Strikes Deal with Anthropic, New Treatment for Pancreatic Cancer 4/10/26
This episode covers rising AI cybersecurity risks, investor Bill Gurley's market analysis, CoreWeave's deal with Anthropic, and a new pancreatic cancer treatment from Revolution Medicines.